Oxygen Reserve Index-Guided Oxygen Titration During Surgery in the Beach Chair Position
ORI-BCP
The Utility of Oxygen Reserve Index Guidance in Inspiratory Oxygen Titration for Patients Undergoing Surgery in the Beach Chair Position: A Prospective Comparative Study
2 other identifiers
interventional
80
1 country
1
Brief Summary
This study aims to evaluate whether guidance by the Oxygen Reserve Index (ORi) improves inspiratory oxygen fraction (FiO₂) titration compared with conventional pulse oximetry (SpO₂)-guided oxygen administration in adult patients undergoing surgery in the beach chair position. Oxygen therapy is routinely used during general anesthesia to prevent hypoxemia; however, excessive oxygen administration may result in hyperoxia, which has been associated with adverse cardiovascular and pulmonary effects. Standard pulse oximetry may not adequately detect hyperoxia when oxygen saturation values are high. In this prospective comparative study, patients will receive oxygen titration guided either by SpO₂ alone or by combined ORi and SpO₂ monitoring. The primary outcome is the incidence of intraoperative hyperoxemia, assessed by arterial blood gas analysis. Secondary outcomes include intraoperative oxygenation parameters and hemodynamic variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2026
CompletedFirst Posted
Study publicly available on registry
February 11, 2026
CompletedStudy Start
First participant enrolled
February 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
February 11, 2026
January 1, 2026
5 months
January 18, 2026
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Intraoperative Severe Hyperoxemia
Severe hyperoxemia will be defined as an arterial partial pressure of oxygen (PaO2) ≥200 mmHg, measured by arterial blood gas analysis at predefined intraoperative time points.
Perioperative/Periprocedural
Secondary Outcomes (4)
Mean Peripheral Oxygen Saturation (SpO2) During Surgery
Perioperative/Periprocedural
Mean Oxygen Reserve Index (ORi) During Surgery
Perioperative/Periprocedural
Mean Fraction of Inspired Oxygen (FiO₂) During Surgery
Perioperative/Periprocedural
Mean Cerebral Oxygen Saturation Measured by Near-Infrared Spectroscopy During Surgery
Intraoperative period (from induction of anesthesia to end of surgery)
Study Arms (2)
ORi-Guided FiO₂ Titration
EXPERIMENTALInspiratory oxygen fraction (FiO₂) will be titrated using combined Oxygen Reserve Index (ORi) and peripheral oxygen saturation (SpO₂) monitoring throughout surgery.
SpO₂-Guided Oxygen Titration
ACTIVE COMPARATORInspiratory oxygen fraction (FiO₂) will be titrated based on peripheral oxygen saturation (SpO₂) values according to routine clinical practice.
Interventions
Inspiratory oxygen fraction (FiO₂) will be adjusted throughout surgery using combined Oxygen Reserve Index (ORi) and peripheral oxygen saturation (SpO₂) monitoring. FiO₂ will be titrated to maintain ORi values between 0.2 and 0.5, with reassessment every 2-3 minutes.
FiO₂ will be adjusted to maintain SpO₂ at or above 98% throughout surgery.
Eligibility Criteria
You may qualify if:
- Adult patients aged 18 to 65 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Scheduled for elective orthopedic surgery in the beach chair position
- Body mass index (BMI) \<35 kg/m²
- Ability to provide written informed consent
You may not qualify if:
- Age \<18 or ≥65 years
- Finger deformities preventing the use of Oxygen Reserve Index (ORi) monitoring
- Severe anemia (hemoglobin \<8 g/dL)
- Pregnancy
- Refusal or inability to provide informed consent
- History of stroke or significant vascular pathology
- Severe cardiac or respiratory disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Provincial Health Directorate Fatih Sultan Mehmet Training and Research Hospital
Istanbul, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
cagla sancak, MD
ISTANBUL PROVINCIAL HEALTH DIRECTORATE FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident in Anesthesiology
Study Record Dates
First Submitted
January 18, 2026
First Posted
February 11, 2026
Study Start
February 15, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
February 11, 2026
Record last verified: 2026-01